Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models Levin ThomasArun Prasath RajuMahadev Rao Review Open access 19 July 2022 Pages: 1535 - 1553
Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses Marina AmeraliMarianna Politou Review Open access 23 July 2022 Pages: 1555 - 1565
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews Reza MajidazarErfan Rezazadeh-GavganiAmirreza Naseri Review 26 July 2022 Pages: 1567 - 1587
A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation Amanda Jia Qi OoiChloe WongChing-Hui Sia Review 09 August 2022 Pages: 1589 - 1600
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use Vitória Segabinazzi FolettoTaciéli Fagundes da RosaRosmari Hörner Review 09 August 2022 Pages: 1601 - 1611
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies Luigi La ViaFilippo SanfilippoMarinella Astuto Review Open access 26 August 2022 Pages: 1613 - 1622
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway Ane Gedde-DahlOlav SpigsetEspen Molden Research Open access 25 July 2022 Pages: 1623 - 1632
Attitudes and beliefs of older adults and caregivers towards deprescribing in French-speaking countries: a multicenter cross-sectional study Barbara RouxBianca RakhejaMarie-Laure Laroche Research 27 July 2022 Pages: 1633 - 1646
Perception of clinical research among patients and healthy volunteers of clinical trials Felix BergmannPeter MatznellerMarkus Zeitlinger Research Open access 27 July 2022 Pages: 1647 - 1655
Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia Wei ZuoBo LiuBing Han Research 03 August 2022 Pages: 1657 - 1666
Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy Nannan YaoShan HuangHongtao Song Research 25 August 2022 Pages: 1667 - 1675
Effect of posaconazole on the concentration of intravenous and oral cyclosporine in patients undergoing hematopoietic stem cell transplantation Li-E ZhuHui-Ping HuangXue-Mei Wu Research 31 August 2022 Pages: 1677 - 1685
Non-persistence to antihypertensive drug therapy in Lithuania Indre TreciokieneNomeda BratcikovieneKatja Taxis Pharmacoepidemiology and Prescription Open access 02 August 2022 Pages: 1687 - 1696
COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed Nadir YalcinKarel Allegaert Perspective 05 August 2022 Pages: 1697 - 1701
Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke? Lixin DuZhigang LiJun Xia Correspondence 25 August 2022 Pages: 1703 - 1704
Correction to: Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke? Lixin DuZhigang LiJun Xia Correction 16 September 2022 Pages: 1705 - 1705
Reply to Lixin Du et al Bojung SeoJialin SuYiqing Song Correspondence 01 September 2022 Pages: 1707 - 1708
Correction to: Trends and variation in benzodiazepine use in nursing homes in the USA Ioannis MalagarisHemalkumar B. MehtaJames S. Goodwin Correction 16 July 2022 Pages: 1709 - 1709